Abstract
The eIF2α kinase general control non-depressible 2 integrates translation initiation rates to amino acid availability. General control non-depressible 2 also regulates translation initiation during synaptic plasticity and GCN2-/- mice show improved memory compared with wild-type mice with a reduced threshold for triggering late long-term potentiation. This property suggests that inhibiting general control non-depressible 2 function might represent a therapeutic avenue for improving memory. We screened for general control non-depressible 2 inhibitors using a small library of known kinase inhibitors and ATP-analogs and identified three compounds - indirubin-3′-monoxime, SP600125 and a SyK inhibitor with activity against general control non-depressible 2. All three compounds inhibit the ability of general control non-depressible 2 to phosphorylate eIF2αin vitro as well as in vivo following UV-treatment of mouse embryonic fibroblasts. Using computer-assisted modeling, we modeled the binding of the inhibitors in the ATP-binding site of general control non-depressible 2. This work provides the molecular basis for undertaking structure-activity relationships of these compounds in order to develop specific inhibitors of general control non-depressible 2. © 2009 John Wiley and Sons A/S.
Author supplied keywords
Cite
CITATION STYLE
Robert, F., Williams, C., Yan, Y., Donohue, E., Cencic, R., Burley, S. K., & Pelletier, J. (2009). Blocking UV-induced eIF2α phosphorylation with small molecule inhibitors of GCN2. Chemical Biology and Drug Design, 74(1), 57–67. https://doi.org/10.1111/j.1747-0285.2009.00827.x
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.